1025MO Preliminary safety, pharmacokinetics and immunomodulatory activity of RBS2418, an oral ENPP1 inhibitor, alone and in combination with pembrolizumab in patients with solid tumors

Authors:
  • TMT.U. Marron
    T.U. Marron
  • JMJ.G. Misleh
    J.G. Misleh
  • CCC. Chen
    C. Chen
  • ZWZ.A. Wainberg
    Z.A. Wainberg
  • JPJ. Powderly
    J. Powderly
  • RBR. Boccia
    R. Boccia
  • MGM. Gordon
    M. Gordon
  • JSJ. Segar
    J. Segar
  • ICI. Csiki
    I. Csiki
  • JSJ.M. Schanzer
    J.M. Schanzer
  • LOL. O'TOole
    L. O'TOole
  • NHN. Huang
    N. Huang

Abstract
No abstract available